These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
587 related articles for article (PubMed ID: 32938202)
1. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis. Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202 [TBL] [Abstract][Full Text] [Related]
2. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657 [TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials. Brunetti ND; Tricarico L; Correale M; De Gennaro L; Santoro F; Ieva R; Di Biase M J Thromb Thrombolysis; 2020 Aug; 50(2):305-310. PubMed ID: 31654194 [TBL] [Abstract][Full Text] [Related]
4. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer. Kirkilesis GI; Kakkos SK; Tsolakis IA Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186 [TBL] [Abstract][Full Text] [Related]
5. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis. Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644 [TBL] [Abstract][Full Text] [Related]
6. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis. Giustozzi M; Agnelli G; Del Toro-Cervera J; Klok FA; Rosovsky RP; Martin AC; Herold J; Tzoran I; Szmit S; Bertoletti L; Becattini C; Huisman MV Thromb Haemost; 2020 Jul; 120(7):1128-1136. PubMed ID: 32365386 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis. Dong Y; Wang Y; Ma RL; Liu M; Gao JZ; Su WY; Yan L; Sun JJ J Thromb Thrombolysis; 2019 Oct; 48(3):400-412. PubMed ID: 31062143 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for the Treatment of Cancer-Associated Thrombosis: A Systematic Review and Network Meta-Analysis of Randomized Trials. Sobieraj DM; Baker WL; Smith E; Sasiela K; Trexler SE; Kim O; Coleman CI Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):182S-187S. PubMed ID: 30244595 [TBL] [Abstract][Full Text] [Related]
9. Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulants. Posch F; Königsbrügge O; Zielinski C; Pabinger I; Ay C Thromb Res; 2015 Sep; 136(3):582-9. PubMed ID: 26210891 [TBL] [Abstract][Full Text] [Related]
10. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Andras A; Sala Tenna A; Stewart M Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and meta-analysis. Carrier M; Cameron C; Delluc A; Castellucci L; Khorana AA; Lee AY Thromb Res; 2014 Dec; 134(6):1214-9. PubMed ID: 25457583 [TBL] [Abstract][Full Text] [Related]
12. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review. Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174 [TBL] [Abstract][Full Text] [Related]
13. Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis. Chen H; Tao R; Zhao H; Jiang J; Yang J Medicine (Baltimore); 2020 Jan; 99(5):e19000. PubMed ID: 32000440 [TBL] [Abstract][Full Text] [Related]
14. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis. Li A; Garcia DA; Lyman GH; Carrier M Thromb Res; 2019 Jan; 173():158-163. PubMed ID: 29506866 [TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for the treatment of cancer-associated thrombosis (which agent for which patient). Pernod G; Joly M; Sonnet B J Med Vasc; 2020 Nov; 45(6S):6S17-6S23. PubMed ID: 33276939 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis. Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142 [TBL] [Abstract][Full Text] [Related]
17. Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism. Patel A; Williams H; Baer MR; Zimrin AB; Law JY Acta Haematol; 2019; 142(4):233-238. PubMed ID: 31108496 [TBL] [Abstract][Full Text] [Related]
18. Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer. Ueyama H; Miyashita H; Takagi H; Cruz C; Burger A; Briasoulis A; Kuno T J Thromb Thrombolysis; 2021 Jan; 51(1):102-111. PubMed ID: 32458316 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trials. Desai R; Koipallil GK; Thomas N; Mhaskar R; Visweshwar N; Laber D; Patel A; Jaglal M Sci Rep; 2020 Nov; 10(1):18945. PubMed ID: 33144679 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]